Usual care as prescribed by the physician as standard of care in clinical practice for the treatment of ABSSSI.

Response to treatment (healthcare provider assessment) comparing response at the Day 14 visit. Response to treatment will be defined through an assessment of erythema (measurement of lesion characteristics) and the absence of fever

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible.

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible.

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible.

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible.

Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible.

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

The SF-12 yields a physical and a mental health component summary score (referred to as physical component summary score [PCS] and mental component summary score [MCS]). The PCS and MCS follow a t-score distribution, i.e. mean of 50 and standard deviation of 10 in the general US population, meaning all scores above or below 50 are above and below the average, respectively, in the US general population.

Cost of hospital inpatient stays, ED visits, healthcare visits, procedures, and biological tests

Total of all reporting groups

Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.

Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.

Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.

Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.

Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.

Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.

Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.

Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.

Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.

Response to treatment (healthcare provider assessment) comparing response at the Day 14 visit. Response to treatment will be defined through an assessment of erythema (measurement of lesion characteristics) and the absence of fever

Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.

Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

FAS population. 43 and 34 patients provided any survey data in the usual care group and the new critical pathway group, respectively. 40 and 32 patients completed all survey questions in the usual care group and new critical pathway group, respectively.

Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible.

FAS population. 43 and 34 patients provided any survey data in the usual care group and the new critical pathway group, respectively. 40 and 32 patients completed all survey questions in the usual care group and new critical pathway group, respectively.

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

FAS population. 43 and 34 patients provided any survey data in the usual care group and the new critical pathway group, respectively. 40 and 32 patients completed all survey questions in the usual care group and new critical pathway group, respectively.

Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible.

FAS population. 43 and 34 patients provided any survey data in the usual care group and the new critical pathway group, respectively. 40 and 32 patients completed all survey questions in the usual care group and new critical pathway group, respectively.

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

43 & 34 patients provided any survey data in the usual care group & new critical pathway group; 40 & 32 patients completed all questions in the usual care group & new critical pathway group; 42 & 34 patients answered this question in the usual care group & new critical pathway group, respectively. Patients may have checked multiple responses.

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

FAS Population. 43 & 34 patients provided any survey data in the usual care group & new critical pathway group; 40 & 32 patients completed all survey questions in the usual care group & new critical pathway group; 43 & 33 patients answered this survey question in the usual care group & new critical pathway group, respectively.

Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible.

FAS Population. 43 & 34 patients provided any survey data in the usual care group & new critical pathway group; 40 & 32 patients completed all survey questions in the usual care group & new critical pathway group; 43 & 33 patients answered this survey question in the usual care group & new critical pathway group, respectively.

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

43 & 34 patients provided any survey data in the usual care group & new critical pathway group; 40 & 32 patients completed all questions in the usual care group & new critical pathway group; 43 & 33 patients answered this question in the usual care group & new critical pathway group, respectively. Patients may have checked multiple responses.

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

43 & 34 patients provided any survey data in the usual care group & new critical pathway group; 40 & 32 patients completed all questions in the usual care group & new critical pathway group; 43 & 33 patients answered this question in the usual care group & new critical pathway group, respectively. Patients may have checked multiple responses.

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

FAS Population. 43 & 34 patients provided any survey data in the usual care group & new critical pathway group; 40 & 32 patients completed all survey questions in the usual care group & new critical pathway group; 42 & 33 patients answered this survey question in the usual care group & new critical pathway group, respectively.

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

FAS Population. 43 & 34 patients provided any survey data in the usual care group & new critical pathway group; 40 & 32 patients completed all survey questions in the usual care group & new critical pathway group; 42 & 33 patients answered this survey question in the usual care group & new critical pathway group, respectively.

Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible.

FAS Population. 43 & 34 patients provided any survey data in the usual care group & new critical pathway group; 40 & 32 patients completed all survey questions in the usual care group & new critical pathway group; 43 & 33 patients answered this survey question in the usual care group & new critical pathway group, respectively.

Patients rated their satisfaction on a 10-point scale, where 0 was the worst experience possible and 10 the best experience possible.

FAS Population. 43 & 34 patients provided any survey data in the usual care group & new critical pathway group; 40 & 32 patients completed all survey questions in the usual care group & new critical pathway group; 43 & 33 patients answered this survey question in the usual care group & new critical pathway group, respectively.

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

FAS Population. 43 & 34 patients provided any survey data in the usual care group & new critical pathway group; 40 & 32 patients completed all survey questions in the usual care group & new critical pathway group; 43 & 34 patients answered this survey question in the usual care group & new critical pathway group, respectively.

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

FAS Population. 43 & 34 patients provided any survey data in the usual care group & new critical pathway group; 40 & 32 patients completed all survey questions in the usual care group & new critical pathway group; 41 & 34 patients answered this survey question in the usual care group & new critical pathway group, respectively.

Patient satisfaction with care as assessed through the ABSSSI Patient Satisfaction Survey (patient reported).

FAS Population. 43 & 34 patients provided any survey data in the usual care group & new critical pathway group; 40 & 32 patients completed all survey questions in the usual care group & new critical pathway group; 43 & 34 patients answered this survey question in the usual care group & new critical pathway group, respectively.

FAS population. 43 and 34 patients provided any survey data in the usual care group and the new critical pathway group, respectively.14 and 9 patients completed all survey questions in the usual care group and new critical pathway group, respectively. 17 and 20 patients were employed.

The SF-12 yields a physical and a mental health component summary score (referred to as physical component summary score [PCS] and mental component summary score [MCS]). The PCS and MCS follow a t-score distribution, i.e. mean of 50 and standard deviation of 10 in the general US population, meaning all scores above or below 50 are above and below the average, respectively, in the US general population.

FAS population. 43 and 34 patients provided any survey data in the usual care group and the new critical pathway group, respectively. 42 and 34 patients completed all survey questions in the usual care group and new critical pathway group, respectively.

Cost of hospital inpatient stays, ED visits, healthcare visits, procedures, and biological tests

Full analysis set (FAS) population consists of all enrolled patients that has received at least one dose of antibiotics or one dose of dalbavancin for inclusion.

The New Critical Pathway under study is defined as (1) use of guideline-based patient identification criteria, and, for those who meet these criteria, (2) use of dalbavancin, administered as a single intravenous (IV) dose of 1500 mg over 30 minutes for the treatment of ABSSSI.